Compass Net Tangible Assets from 2010 to 2025

CMPX Stock  USD 3.33  0.26  8.47%   
Compass Therapeutics Net Tangible Assets yearly trend continues to be fairly stable with very little volatility. Net Tangible Assets are likely to outpace its year average in 2025. Net Tangible Assets is the total assets of Compass Therapeutics minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2010-12-31
Previous Quarter
208.9 M
Current Value
219.3 M
Quarterly Volatility
130.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Compass Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compass Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 7.7 M or Interest Income of 7.7 M, as well as many indicators such as Price To Sales Ratio of 187, Dividend Yield of 0.0 or PTB Ratio of 1.18. Compass financial statements analysis is a perfect complement when working with Compass Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Compass Stock
Check out the analysis of Compass Therapeutics Correlation against competitors.
For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Latest Compass Therapeutics' Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Compass Therapeutics over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Compass Therapeutics' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Compass Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Slightly volatile
   Net Tangible Assets   
       Timeline  

Compass Net Tangible Assets Regression Statistics

Arithmetic Mean5,621,349
Geometric Mean105,252,276
Coefficient Of Variation2,329
Mean Deviation117,222,811
Median(84,774,000)
Standard Deviation130,940,204
Sample Variance17145.3T
Range337.9M
R-Value0.85
Mean Square Error5253T
R-Squared0.71
Significance0.000038
Slope23,240,280
Total Sum of Squares257180.1T

Compass Net Tangible Assets History

2025219.3 M
2024208.9 M
2022181.6 M
2021140.1 M
202039.9 M
2019-118.6 M

About Compass Therapeutics Financial Statements

Compass Therapeutics investors use historical fundamental indicators, such as Compass Therapeutics' Net Tangible Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Compass Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Tangible Assets208.9 M219.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.